Trial · NCT07219602
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 19 of 19
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The percent change from Baseline to Day 84 in LDL-C compared with placebo for the following treatment groups: - obicetrapib 10 mg + ezetimibe 10 mg FDC treatment group; and - obicetrapib 10 mg monotherapy treatment group | 84 days | |
| Secondary | Percent change from Baseline to Day 84 in non-HDL-C for the obicetrapib 10 mg + ezetimibe 10 mg FDC treatment group compared with the placebo group | Day 84 | |
| Secondary | Percent change from Baseline to Day 84 in HDL-C for the obicetrapib 10 mg + ezetimibe 10 mg FDC treatment group compared with the placebo group | 84 days | |
| Secondary | Percent change from Baseline to Day 84 in ApoB for the obicetrapib 10 mg + ezetimibe 10 mg FDC treatment group compared with the placebo group | 84 days | |
| Secondary | Percent change from Baseline to Day 84 in ApoA1 for the obicetrapib 10 mg + ezetimibe 10 mg FDC treatment group compared with the placebo group | 84 days | |
| Secondary | Percent change from Baseline to Day 84 in non-HDL-C for the obicetrapib 10 mg monotherapy treatment group compared with the placebo group; | 84 days | |
| Secondary | Percent change from Baseline to Day 84 in HDL-C for the obicetrapib 10 mg monotherapy treatment group compared with the placebo group | Day 84 | |
| Secondary | Percent change from Baseline to Day 84 in ApoB for the obicetrapib 10 mg monotherapy treatment group compared with the placebo group | Day 84 | |
| Secondary | Percent change from Baseline to Day 84 in ApoA1 for the obicetrapib 10 mg monotherapy treatment group compared with the placebo group | Day 84 | |
| Secondary | Percent change from Baseline to Day 84 in lipoprotein (a) (Lp[a]) for the obicetrapib 10 mg + ezetimibe 10 mg FDC treatment group compared with the placebo group | Day 84 | |
| Secondary | Percent change from Baseline to Day 84 in Lp(a) for the obicetrapib 10 mg monotherapy treatment group compared with the placebo group | Day 84 | |
| Other | Percent change from Baseline over time in LDL-C | 40 weeks | The percent change from Baseline at every visit for LDL-C |
| Other | Proportion of participants that achieve LDL-C <100 mg/dL (<2.6 mmol/L), LDL-C <70 mg/dL (<1.8 mmol/L), and LDL-C <55 mg/dL (<1.4 mmol/L) | 40 weeks | The percent change from Baseline at every visit in the proportion of participants that achieve LDL-C \<100 mg/dL (\<2.6 mmol/L), LDL-C \<70 mg/dL (\<1.8 mmol/L), and LDL-C \<55 mg/dL (\<1.4 mmol/L) |
| Other | Percent change from Baseline over time in non-HDL-C | 40 weeks | The percent change from Baseline at every visit for non-HDL-C |
| Other | Percent change from Baseline over time in ApoB | 40 weeks | The percent change from Baseline at every visit in ApoB |
| Other | Percent change from Baseline over time in total cholesterol | 40 weeks | The percent change from Baseline at every visit for total cholesterol |
| Other | Percent change from Baseline over time in triglycerides | 40 weeks | The percent change from baseline at every visit for triglycerides |
| Other | Percent change from Baseline over time in HDL-C | 40 weeks | the percent change from Baseline at every visit for HDL-C |
| Other | Percent change from Baseline over time in Lp(a) | 40 weeks | the percent change from Baseline at every visit for Lp(a) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07219602/registered